U.S. Markets open in 7 hrs 48 mins
S&P Futures
3,634.75+2.00(+0.06%)Dow Futures
29,992.00-6.00(-0.02%)Nasdaq Futures
12,111.00+35.00(+0.29%)
GlaxoSmithKline plc (GSK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
37.09+0.35 (+0.95%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 36.74 |
| Open | 36.77 |
| Bid | 0.00 x 1400 |
| Ask | 0.00 x 3100 |
| Day's Range | 36.72 - 37.21 |
| 52 Week Range | 31.43 - 48.25 |
| Volume | 4,940,267 |
| Avg. Volume | 4,372,952 |
| Market Cap | 92.049B |
| Beta (5Y Monthly) | 0.31 |
| PE Ratio (TTM) | 37.39 |
| EPS (TTM) | 0.99 |
| Earnings Date | Feb 01, 2017 - Feb 06, 2017 |
| Forward Dividend & Yield | 2.03 (5.52%) |
| Ex-Dividend Date | Nov 12, 2020 |
| 1y Target Est | 48.17 |
- Editor's PickYahoo Finance
Coronavirus update: HHS puts vaccine distribution in states' power; Wall Street analysts project lifelong vaccine protection
With three vaccine candidates out with a first look at efficacy data, Wall Street is more optimistic about the light at the end of the pandemic tunnel.
- Zacks
The Zacks Analyst Blog Highlights: UnitedHealth, CRM, GSK, Square and American Electric Power
The Zacks Analyst Blog Highlights: UnitedHealth, CRM, GSK, Square and American Electric Power
- Zacks
Glaxo's (GSK) RSV Vaccine for Pregnant Women Enters Phase III
Glaxo (GSK) is developing vaccine against respiratory syncytial virus for pediatric patients, pregnant women and older adults. The candidates hold significant potential.
© 2020 Verizon Media. All rights reserved.
